Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication,
belonging to the group of incretin mimetics, approved in April 2005 for the
Jun 15, 2016 ... Exenatide injection may increase the risk that you will develop tumors of the
thyroid gland, including medullary thyroid carcinoma (MTC; a type ...
Easy to read patient leaflet for exenatide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Dec 19, 2014 ... DRUG CLASS AND MECHANISM: Exenatide is an injectable drug that reduces
the level of sugar (glucose) in the blood. It is used for treating ...
Description, Exenatide, derived from a compound found in the saliva of the Gila
monster, a large lizard native to the southwestern US, is a functional analog of ...
Byetta (exenatide) is an injectable diabetes medicine that helps control blood
sugar levels. Exenatide is used to treat type 2 (non-insulin dependent) diabetes.
Following a standardized meal, BYETTA<sup>®</sup> (exenatide) injection reduced elevated
PPG excursions to a nearly flat profile in patients with type 2 diabetes.
May 4, 2005 ... The FDA will also consider approval of exenatide as monotherapy for patients
with type 2 diabetes. Exenatide, the first drug in the new class of ...
Medscape - Type 2 diabetes-specific dosing for Byetta (exenatide), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
Exenatide is an antidiabetic injection that is used in treating type 2 diabetes.
Read more about diabetes treatments and antidiabetic injections at Patient.